Jane Henderson - 30 Jan 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Financial Officer
Signature
/s/ Jane Henderson
Issuer symbol
IVVD
Transactions as of
30 Jan 2022
Net transactions value
$0
Form type
4
Filing time
01 Feb 2022, 17:15:40 UTC
Previous filing
05 Aug 2021
Next filing
13 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +175,000 $0.000000 175,000 30 Jan 2022 Common Stock 175,000 $6.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.